BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26356543)

  • 1. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
    Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P
    J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
    Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P
    Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma mimicking dermal and Spitz's nevus ("nevoid" melanoma).
    Wong TY; Duncan LM; Mihm MC
    Semin Surg Oncol; 1993; 9(3):188-93. PubMed ID: 8516601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
    Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
    [No Abstract]   [Full Text] [Related]  

  • 12. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
    Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
    Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
    Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
    Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization analysis of atypical melanocytic proliferations and melanoma in young patients.
    DeMarchis EH; Swetter SM; Jennings CD; Kim J
    Pediatr Dermatol; 2014; 31(5):561-9. PubMed ID: 24924836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
    Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
    Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings.
    Pouryazdanparast P; Haghighat Z; Beilfuss BA; Guitart J; Gerami P
    Am J Surg Pathol; 2011 Sep; 35(9):1405-12. PubMed ID: 21836476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dermal-based borderline melanocytic tumor: a categorical approach.
    Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
    J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevoid malignant melanoma.
    Schmoeckel C; Castro CE; Braun-Falco O
    Arch Dermatol Res; 1985; 277(5):362-9. PubMed ID: 4026378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual variants of malignant melanoma.
    Barnhill RL; Gupta K
    Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.